Why This Landed on My Radar
Ascension just sold its stake in a profitable Arizona Medicaid plan to Aetna, and if you think that’s just another health system reshuffling assets, look closer. When one of the country’s largest nonprofit hospital systems decides to exit insurance risk - specifically walking away from a profitable plan focused on dual-eligible patients - it tells us something about where the big players think healthcare economics are heading. And that shift affects how we negotiate, how we think about risk-based contracts, and what leverage we have left.
Here’s What’s Going On
Ascension is selling its ownership stake in Mercy Care, an Arizona Medicaid managed care plan, to Aetna (CVS Health). Mercy Care isn’t some struggling venture - it’s a profitable insurer serving high-margin dual-eligible members, exactly the kind of population that should be attractive in a value-based care world. Ascension co-owned the plan with CommonSpirit’s Dignity Health since 1985, so this isn’t a failed experiment; it’s a deliberate strategic exit.
The timing matters. Ascension has been systematically trimming its portfolio, and this sale continues that pattern. But here’s what’s significant: they’re shedding insurance risk and letting a national payer consolidate more control in a state Medicaid market. Aetna gets a stronger foothold in Arizona with an established plan that already has relationships, infrastructure, and profitability in a complex, high-need population.
For context, dual-eligible patients (Medicare + Medicaid) represent some of the most medically complex and historically profitable lives in managed care when you can manage them well. These are exactly the patients value-based contracts are built around. Ascension walking away suggests they’ve decided the juice isn’t worth the squeeze - even when there’s actual juice.
What This Means for Your Practice
This deal is a microcosm of a bigger trend that directly affects our practices in Texas: health systems are retreating from insurance risk while payers are doubling down. Let’s connect the dots to our reality.
First, in Texas we’re already dealing with massive payer consolidation. BCBS Texas and United Healthcare dominate our commercial market, and now we’re watching national players like Aetna/CVS expand their Medicaid footprints in other states. When health systems exit the insurance game, it means fewer entities willing to take on insurance risk - and more power concentrated with traditional payers. That’s not great for independent practices trying to negotiate fair contracts or push back on prior authorization madness.
Second, the dual-eligible population is particularly relevant because Texas has the largest uninsured population in the nation and no Medicaid expansion. Our Medicaid patients are often the most complex, and the dual-eligible subset requires serious care coordination. If health systems with massive resources are deciding this population isn’t worth the administrative and financial risk, what does that tell us about the MA-Medicaid contracts some of us are being pitched?
Third - and this is the part that should make you think about your own practice strategy - Ascension’s exit suggests that owning the insurance risk isn’t where the value is anymore. They’re essentially saying: “We’ll stick to delivering care; let Aetna deal with actuarial risk, regulatory compliance, and claims processing.” For independent practices, this reinforces something we’ve suspected: taking on full risk without the infrastructure, data analytics, and scale is extraordinarily difficult. The practices winning with value-based care aren’t going full-risk; they’re finding upside-only arrangements, using better HCC capture under V28 to maximize MA revenue, and building the care coordination infrastructure that actually moves the needle on quality metrics.
The GLP-1 opportunity is a good parallel here. We don’t need to become pharmacies to win; we need to be smart about which patients benefit, document comprehensively for risk adjustment, and create systems that keep these patients engaged long-term. Similarly, we don’t need to become insurance companies - we need to be strategically smart about which risk arrangements make sense and which are just payers offloading their headaches onto us without adequate support or upside.
Key Takeaways
- Health system exits from insurance risk = more payer consolidation and leverage, which affects our contract negotiations in Texas markets
- Dual-eligible and complex Medicaid populations require infrastructure - if Ascension won’t take the risk, make sure you’re adequately compensated and supported before you do
- V28 HCC documentation matters more than ever - accurate risk adjustment on your MA patients is how you get paid fairly without taking on full insurance risk
- Evaluate risk-based contracts with extreme scrutiny - upside-only or limited-risk models protect your practice while national trends show even large systems are walking away from full risk
- The winning play is better systems, not more risk - invest in care coordination, coding accuracy, and patient engagement rather than chasing full-risk contracts you’re not equipped to manage
What Smart Practices Are Doing
Forward-thinking independent practices are saying no to full-risk contracts unless the data infrastructure, stop-loss protection, and upside truly justify it. Instead, they’re focusing on maximizing revenue from existing MA patients through comprehensive HCC capture, building chronic care management programs that actually generate revenue, and creating patient-pay offerings (like GLP-1 programs) that aren’t subject to payer whims.
Source
“Ascension sells ownership in Arizona Medicaid plan to Aetna” - Healthcare Dive
Primary Care Perspective delivers curated intelligence from trusted healthcare sources.
© 2026 Primary Care Perspective | Texas Edition